Meliora Therapeutics focuses on advancing oncology drug development for the 21st century. The company is dedicated to creating novel therapeutic solutions to address unmet needs in cancer treatment. Their work centers on bringing forward new pharmaceutical agents through rigorous development pipelines.
Funding
$11M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
ZFounders
Product
Problem
The high failure rate of cancer therapies in clinical trials highlights a critical need for improved drug development processes. Many existing cancer drugs have misidentified mechanisms of action, leading to ineffective treatments and poor patient outcomes. A lack of accurate understanding of how drugs interact with cancer biology hinders the development of targeted and effective therapies.
Solution
Meliora Therapeutics is developing a novel approach to precision oncology drug discovery by creating a machine learning-powered atlas of drug mechanisms and their impact on cancer biology. This mechanism-of-action atlas enables the identification of potent compounds that inhibit key cancer targets, facilitating the development of more effective cancer therapies. By leveraging modern molecular fingerprinting, machine learning, and cutting-edge biology, Meliora moves beyond traditional binding-based drug development to identify the true mechanisms-of-action of chemical compounds. This approach allows for more accurate, effective, and rapid drug development, ultimately improving patient outcomes. The platform provides novel mechanistic insights on existing molecules and identifies promising starting scaffolds for de novo discovery programs.
Target Audience
Meliora's primary customers are researchers and pharmaceutical companies involved in oncology drug discovery and development.
Features
- Machine learning-powered atlas of drug mechanisms and their impact on cancer biology
- Target-agnostic approach to identify potent compounds that inhibit key cancer targets
- Identification of true mechanisms-of-action of chemical compounds
- Modern molecular fingerprinting techniques
- Genomic and computational techniques